Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BA 1201

Next Previous
X
Search
Drug Profile

BA 1201

Alternative Names: Anti-PDL1/TGF-bifunctional fusion protein - Shandong Boan Biotechnology; BA-1201; TS-1905

Latest Information Update: 19 Feb 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Shandong Boan Biotechnology
  • Developer Luye Pharma Group; Shandong Boan Biotechnology
  • Class Antineoplastics; Bispecific antibodies; Immunotherapies; Recombinant fusion proteins
  • Mechanism of Action Antibody-dependent cell cytotoxicity; Programmed cell death-1 ligand-1 inhibitors; T lymphocyte stimulants; Transforming growth factor beta inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Cervical cancer
  • Discontinued Cancer; Cholangiocarcinoma; Gastric cancer; Gastrointestinal cancer; Non-small cell lung cancer; Small cell lung cancer; Urogenital cancer

Most Recent Events

  • 19 Feb 2024 Discontinued - Phase-I for Gastrointestinal cancer (Late-stage disease) in China (Parenteral) (Shandong Boan Biotechnology pipeline February 2024)
  • 19 Feb 2024 Discontinued - Phase-I for Non-small cell lung cancer in China (Parenteral) (Shandong Boan Biotechnology pipeline February 2024)
  • 19 Feb 2024 Discontinued - Phase-I for Small cell lung cancer in China (Parenteral) (Shandong Boan Biotechnology pipeline February 2024)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top